LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
142,400
-4,300 (-2.93%)
Sep 26, 2025, 3:30 PM KST
-2.93%
Market Cap5.19T
Revenue (ttm)148.28B
Net Income (ttm)1.75B
Shares Out36.41M
EPS (ttm)47.94
PE Ratio2,960.11
Forward PE103.02
Dividendn/a
Ex-Dividend Daten/a
Volume406,242
Average Volume386,120
Open145,900
Previous Close146,700
Day's Range139,200 - 146,200
52-Week Range89,500 - 167,700
Beta0.85
RSI42.14
Earnings DateNov 14, 2025

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.